Multiple Myeloma : An international update
(Including ASH update on Haemato-Oncology)
S.P. Jain Auditorium, Bombay Hospital
Marine Lines, Mumbai, India
6-8 January 2006 (Fri-Sun)
Scientific programme (Provisional)
Friday, 6th January 2006
Time | Subject | Speaker |
08.30 am . | Breakfast and registration | |
09.25 am | ASH update - An introduction | Tapan Saikia |
09.30 am | Myeloid malignancies (AML, MDS) | M.B. Agarwal |
10.15 am | Chronic myeloid leukaemia | Tapan Saikia |
11.00 am | Tea / coffee | |
11.30 am | Non-Hodgkin’s lymphoma | K. Smruti |
12.15 pm | Acute lymphoblastic leukaemia | Mukesh Desai |
01.00 pm | Lunch | |
02.00 pm | Inauguration (Multiple myeloma : An international update) | |
02.30 pm | MM : An odyssey of discovery | Robert Kyle |
03.00 pm | MM : Clinical picture | Angela Dispenzieri |
03.30 pm | Case discussions - 1 | Morie GertzSunder Jagannath |
04.00 pm | Tea / coffee | |
04.30 pm | Myeloma : Disease biology - Newer aspects | Nikhil Munshi |
05.00 pm | Myeloma bone disease | Morie Gertz |
05.30 pm | Waldenstrom macroglobulinemia : Diagnosis | Steven Treon |
06.00 pm | Case discussion - 2 | Mohamad HusseinSteven Treon |
07.00 pm | Sponsored lecture (Janssen Cilag)Bortezomib - VelcadeVelcade : Indian experienceVenue : S.P. Jain Auditorium | Sunder JagannathM.B. Agarwal |
07.45 pm | Cultural programmeCocktails and dinnerSponsors : IntasVenue : To be announced |
Saturday, 7th January 2006
Time | Subject | Speaker |
07.00 am | Meet the expert sessions | |
Hall A - Amyloidosis | Morie Gertz | |
Hall B - MGUS | Robert Kyle | |
Hall C - Prognostic factors determining therapy | Nikhil Munshi | |
Hall D - Diagnosis of myeloma | Angela Dispenzieri | |
Hall E - Waldenstrom macroglobulinemia | Steven Treon | |
09.00 am | MGUS, smouldering myeloma | Robert Kyle |
09.30 am | Solitary plasmacytoma (osseous and extra-osseous) cryoglobulinemia | Morie Gertz |
10.00 am | Osteosclerotic myeloma, POEMS syndrome, IgD myeloma, plasma cell leukaemia | Angela Dispenzieri |
10.30 am | Case discussion - 3 | Nikhil MunshiAngela Dispenzieri |
11.00 am | Tea / coffee | |
11.30 am | Waldenstrom macroglobulinemia : Prognosis | Steven Treon |
12.00 pm | Myeloma : Investigations including FLC assay and significance of circulating plasma cells | Vincent Rajkumar |
12.30 pm | Case discussion - 4 | Robert KyleVincent Rajkumar |
01.00 pm | Lunch | |
02.00 pm | Amyloidosis | Morie Gertz |
02.30 pm | Monoclonal gammopathy related neuropathies and nephropathy | Angela Dispenzieri |
03.00 pm | Treatment of newly diagnosed myeloma | Vincent Rajkumar |
03.30 pm | Case discussion - 5 | Morie GertzSunder Jagannath |
04.00 pm | Tea / coffee | |
04.30 pm | Transplants - Auto, tandem, allo, reduced intensity | Sunder Jagannath |
05.00 pm | Novel targets in myeloma therapy | Nikhil Munshi |
05.30 pm | Case discussion - 6 | Mohamad HusseinSteven Treon |
06.30 pm onwards | Sponsored lecture (Novo Nordisk)Novo Seven : A universal haemostatic agentVenue : To be announced | M.B. Agarwal |
07.30 pm | Cultural programmeCocktails and dinnerVenue : To be announced |
Sunday, 8th January 2006
Time | Subject | Speaker |
07.00 am | Meet the expert sessions | |
Hall A - Conventional management of myeloma | Angela Dispenzieri | |
Hall B - Bortezomib | Sunder Jagannath | |
Hall C - Support therapy | Mohamad Hussein | |
Hall D - Thalidomide | Vincent Rajkumar | |
Hall E - Therapy of relapsed myeloma | Nikhil Munshi | |
09.00 am | IMiDs : Thalidomide, Lenalidomide | Vincent Rajkumar |
09.30 am | Arsenic trioxide, Liposomal Doxorubicin | Mohamad Hussein |
10.00 am | Waldenstrom macroglobulinemia : Management | Steven Treon |
10.30 am | Case discussion - 7 | Nikhil MunshiAngela Dispenzieri |
11.00 am | Tea / coffee | |
11.30 am | Novel combination therapies : Principles and practice | Mohamad Hussein |
12.00 pm | Treatment of refractory and relapsed myeloma, Maintenance therapy | Sunder Jagannath |
12.30 pm | Case discussion - 8 | Robert KyleVincent Rajkumar |
01.00 pm | Lunch | |
02.00 pm | Support therapy | Robert Kyle |
02.30 pm | Veno-occlusive disease in myeloma | Mohamad Hussein |
03.00 pm | Cytogenetics, genomics, immunotherapy and future challenges | Nikhil Munshi |
03.30 pm | Concluding remarks | M.B. Agarwal |
03.35 pm | High tea |
Proposed case discussions (subject titles to be selected by the speakers)
Session 1 |
Morie GertzSunder Jagannath |
Session 2 |
Mohamad HusseinSteven Treon |
Session 3 |
Nikhil MunshiAngela Dispenzieri |
Session 4 |
Robert KyleVincent Rajkumar |
Session 5 |
Morie GertzSunder Jagannath |
Session 6 |
Mohamad HusseinSteven Treon |
Session 7 |
Nikhil MunshiAngela Dispenzieri |
Session 8 |
Robert KyleVincent Rajkumar |
Kindly visit the website - www.hemato-onco.com for all the details of this meeting including registration.